This item is not currently available in your region.
- Reliably detect JAK2 V617F/G1849T mutation in blood cancer #myeloproliferative neoplasms. Find out more at booth 25… https://t.co/773T0DphM5, Dec 12
- Prof. Kurt Zatloukal discusses how #NGS enables disease insights. View his talk here: https://t.co/OANiRlekff https://t.co/hVgbcDggje, Dec 12
- Optimize the NGS workflow yourself or get a preoptimized system. Find out how at booth 2516 #ASH2017 https://t.co/tjZEc2ajCW, Dec 12
- CALR and JAK2 have prognostic significance? Find out more at #ASH2017 booth 2516 https://t.co/PJnhD9muBN https://t.co/vWksixlmIa, Dec 12
- Improve CALR detection in MPN patients with a new ipsogen CALR assay. Visit #QIAGEN #ASH2017 at booth 2516 for deta… https://t.co/FPs9hzcNDa, Dec 12
MOST POPULAR TAGS
ALK AMP Global ASCO biobarker biomarker blood cancer BRCA breast cancer CALR CDx cfDNA clinical guidelines companion diagnostics ctDNA EGFR ESMO GeneReader Infographic ipsogen JAK2 leukemia liquid biopsy lung cancer MET Mirati Modaplex molecular diagnostics MPN myeloproliferative neoplasms NGS NSCLC Oncology pathology patient testing personalized healthcare plasma precision medicine press release prognostic biomarker QIAGEN QIAGEN Clinical Insight sequencing Therawis TKI UGT1A1